Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-12-067597
Filing Date
2012-12-31
Accepted
2012-12-31 13:32:50
Documents
1
Period of Report
2012-12-28

Document Format Files

Seq Description Document Type Size
1 rrd365166.html 4  
1 rrd365166.xml 4 3890
  Complete submission text file 0001181431-12-067597.txt   5428
Mailing Address 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195
Business Address 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195 847-908-1604
Sagent Pharmaceuticals, Inc. (Issuer) CIK: 0001369786 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SAGENT PHARMACEUTICALS,INC. 1901 N. ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195
Business Address
Logerfo Michael (Reporting) CIK: 0001518010 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35144 | Film No.: 121293141